| May 1, 2014 | ISSUE NUMBER 349 VOL 4 |
Pfizer–AstraZeneca
The UK: Rx for America’s Pharma Tax Blues?
The dizzying flurry of press releases from both Pfizer Inc. and AstraZeneca over the possible Pfizer acquisition of AZ have Rx experts on both sides of the Atlantic buzzing. But from the US side, the most frequent thing that Tom Norton has heard over the last few days is, “You have got to be kidding! ...Read more
Rymax Marketing Services is a one-stop shop for medical meetings and event planners offering unique experiences and services. We create sales incentive and loyalty programs designed to increase employee and customer retention. With 300 aspirational, high equity brands and exclusive rewards to compliment signature events, we ship directly from our nationwide warehouses to help drive our clients’ ROI and revenue. www.rymaxinc.com/customer-loyalty.aspx
Social Media
Filling the Digital Skills Gap
Type 'digital marketing training' into your favorite search engine and you'll be overwhelmed by opportunities to spend your training budget. But signing your team up for a couple of courses isn't the whole answer, writes Peter Houston
...Read more
Social Media
Is Pharma Listening to Diabetes Patients in China?
In China, diabetes patients are hungry for information about their condition, and are taking to social media to discuss it. But, asks Simon Li, is pharma paying attention?
...Read more
Adam Smith Conferences’ Russian Pharmaceutical Forum
Fresh and innovative programme offers plenty of topics and themes to stimulate lively and constructive discussions. HEARover 100 expert speakers (Novartis, AstraZeneca, Pfizer, Teva, Stada, Takeda, Dr.Reddys), EXPERIENCE sessions sharing the best pharmaceutical practices (Generics vs Brands, Biogeneric Producers vs Biological Innovators, Patient Advocacy), LISTEN to special guest addresses (Multichannel Marketing Strategy) and GATHER inspirational ideas from executive debates (Distribution Strategy).
Date: June 17 - 19, 2014
Location: St.Petersburg, Russia
Venue: Corinthia St.Petersburg Hotel
Contact: Lyudmyla Durneva
+44 (0) 207 551 9065
Lyudmyla@adamsmithconferences.com
Website: www.adamsmithconferences.com/as2279PHEX
Industry Forecast
Mission Critical: Assessing Pharma’s Drivers of Change
Four commercial line executives serve as our jury of peers on what's in store for the future of pharma, and discuss the changing criteria for market success, from drugs to consumer products to vaccines ...Read more
Regulatory
Medicare Data Raises Questions About Drug Costs
Recently released Medicare data on payments to individual doctors doesn’t provide specifics on prescription drug outlays, but opens the door to scrutiny of Medicare reimbursement for medicines delivered in physician offices, writes Jill Wechsler ...Read more
|
|
|
|
 //Coherus Biosciences, Inc. (Redwood City, CA) appointed Michael A. Fleming as Senior Vice President, Commercial Strategy.//Tauriga Sciences, Inc. (Los Angeles, CA) announced that Lawrence A. May, M.D., has accepted the position of Chief Medical Officer.//Healthcare communications company Palio+Ignite (New York, NY) announced the appointment of Kim Johnson as President.//Charles M. Baum, M.D., Ph.D., President and Chief Executive Officer of Mirati Therapeutics, joined the Board of Directors of Array BioPharma, Inc. (Boulder, CO).// |
|
|
|
|
|
